CI
CRL icon

Cambiar Investors’s Charles River Laboratories CRL Stock Holding History

Cambiar Investors’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40,665
Closed -$6.12M – 153
2025
Q1 		$6.12M Buy
40,665
+615
+2% +$103K 0.26% 90
2024
Q4 		$7.39M Sell
40,050
-5,880
-13% -$1.13M 0.29% 87
2024
Q3 		$9.05M Buy
45,930
+494
+1% +$103K 0.35% 85
2024
Q2 		$9.39M Buy
45,436
+316
+0.7% +$71.6K 0.37% 84
2024
Q1 		$12.2M Sell
45,120
-15,093
-25% -$3.6M 0.46% 74
2023
Q4 		$14.2M Buy
60,213
+9,651
+19% +$1.9M 0.56% 56
2023
Q3 		$9.91M Buy
50,562
+1,811
+4% +$372K 0.42% 79
2023
Q2 		$10.2M Buy
48,751
+5,664
+13% +$1.13M 0.43% 76
2023
Q1 		$8.7M Buy
43,087
+8,607
+25% +$1.95M 0.37% 81
2022
Q4 		$7.51M Buy
34,480
+2,387
+7% +$521K 0.34% 83
2022
Q3 		$6.32M Buy
32,093
+948
+3% +$205K 0.32% 81
2022
Q2 		$6.66M Sell
31,145
-355
-1% -$86.7K 0.3% 82
2022
Q1 		$8.95M Buy
+31,500
New +$9.71M 0.34% 74
2021
Q2 		– Sell
-22,661
Closed -$6.57M – 150
2021
Q1 		$6.57M Buy
22,661
+2,919
+15% +$811K 0.23% 89
2020
Q4 		$4.93M Sell
19,742
-4,537
-19% -$1.08M 0.19% 86
2020
Q3 		$5.5M Sell
24,279
-3,076
-11% -$638K 0.25% 68
2020
Q2 		$4.77M Sell
27,355
-5,110
-16% -$816K 0.22% 72
2020
Q1 		$4.1M Buy
+32,465
New +$4.87M 0.21% 67

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Cambiar Investors's CRL Position: Q2 2025 in Review

Cambiar Investors sold out of Charles River Laboratories (CRL) in Q2 2025, closing a stake of 40,665 shares — an estimated $6.12M sold.

Cambiar Investors first reported a position in CRL in Q1 2020 and held it in 18 quarters. The position peaked at $14.2M in Q4 2023. 519 funds tracked by Wall St. Rank hold CRL as of Q2 2025.

  • Cambiar Investors reported no remaining Charles River Laboratories position as of Q2 2025 after selling out during the quarter.
  • Cambiar Investors sold 40,665 Charles River Laboratories shares in Q2 2025, an estimated $6.12M.
  • Cambiar Investors first reported a position in Charles River Laboratories in Q1 2020 and held it in 18 quarters.
  • Cambiar Investors's Charles River Laboratories position peaked at $14.2M in Q4 2023.
  • 519 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2025.

Based on Cambiar Investors's 13F filing for Q2 2025, filed 5 Aug 2025.